Real-World Outcomes of Emicizumab in Hemophilia A with or without FVIII Inhibitors from the Canadian Hemophilia Bleeding Disorder Registry
- Resource Type
- Abstract
- Source
- In
Blood 15 November 2022 140 Supplement 1:8465-8467 - Subject
- Language
- ISSN
- 0006-4971